Harte-Hanks (NYSE: HHS) reported Q3 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $146.5 million versus the consensus estimate of $151.78 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.